{"id":"W4381136693","doi":"10.1016/j.annonc.2023.06.002","title":"ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":28,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Hospital Foundation; Queen's University","funders":"Genentech; Servier; European Society for Medical Oncology; Fondazione Beretta; Ipsen; BeiGene; Eisai; Jazz Pharmaceuticals; Gilead Sciences; European Federation of Pharmaceutical Industries and Associations; European Commission; Sanofi; Astellas Pharma; Celldex Therapeutics; Amgen; Pfizer; Celgene; Eli Lilly and Company; AstraZeneca; Seagen; Agios Pharmaceuticals","keywords":"Medicine; Clinical trial; Internal medicine; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001739864,0.0001568492,0.00135691,0.0002415944,0.00006864236,0.000008944618,0.0003477531,0.000432788,0.0002837377],"category_scores_gemma":[0.0008547484,0.0001689271,0.0004504951,0.0002272444,0.0003372699,0.0001804079,0.0001298638,0.0001457363,0.0003977359],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002548002,"about_ca_system_score_gemma":0.00009799426,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001741488,"about_ca_topic_score_gemma":0.00007551638,"domain_scores_codex":[0.9975048,0.00002207721,0.001593061,0.0004012657,0.00003713087,0.0004416353],"domain_scores_gemma":[0.9977477,0.0005746508,0.001035545,0.000305501,0.0002154971,0.00012106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001118146,0.0008988649,0.5035782,0.0002960864,0.0002533366,0.00001968112,0.0005172972,0.000289012,0.00009461631,0.3232347,0.1300739,0.03962621],"study_design_scores_gemma":[0.00199436,0.00284516,0.3926277,0.00004480415,0.00001957977,0.000005506852,0.0001541204,0.0004275754,0.001713679,0.1140657,0.4858012,0.0003004951],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9683384,0.0006795034,0.000216206,0.003892847,0.0009632131,0.000287264,0.0005100104,0.00003890481,0.02507365],"genre_scores_gemma":[0.9936833,0.002580161,0.001193162,0.001012302,0.0001992881,0.00004021254,0.00004231157,0.00002258348,0.001226649],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3557274,"threshold_uncertainty_score":0.6888647,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2509559698425497,"score_gpt":0.4150580455189408,"score_spread":0.1641020756763911,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}